Investigation of Metabolic and Immunological Biomarkers in Tissue and Peripheral Blood of Patients With Chronic Rhinosinusitis With Nasal Polyposis
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory disease of the sinonasal mucosa whose metabolic and immunologic mechanisms are incompletely understood. This prospective case-control study aims to characterize metabolic and immunologic biomarkers in patients with CRSwNP compared with control subjects. Nasal tissue and peripheral blood samples will be analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for free amino acid and carnitine/acylcarnitine profiles, and levels of interleukin-40 (IL-40), interleukin-6 (IL-6), and hypoxia-inducible factor-1 alpha (HIF-1α) will be measured by ELISA. The findings are expected to contribute to understanding disease pathogenesis and to identifying potential diagnostic biomarkers and therapeutic targets.
• Age 18 years or older
• Diagnosis of chronic rhinosinusitis with nasal polyps at the Otorhinolaryngology outpatient clinic
• Diagnosis of nasal polyposis confirmed by histopathological examination of a punch biopsy or surgical specimen
• No condition preventing the collection of tissue and peripheral blood samples within the scope of the study
• Age 18 years or older
• No history of nasal polyposis or chronic rhinosinusitis
• Scheduled for septoplasty, rhinoplasty or similar nasal surgery for reasons other than nasal polyps
• Collection of a healthy nasal mucosa biopsy during surgery poses no additional risk